The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combination of a polyamine-free oral nutritional supplement (ONS) with docetaxel in castrate-resistant prostate cancer (CRPC) patients (pts): A phase II trial.
Bernard G Cipolla
Consultant or Advisory Role - Nutrialys Medical Nutrition (U)
Stock Ownership - Nutrialys Medical Nutrition
Xavier Artignan
No relevant relationships to disclose
Laurent Miglianico
Stock Ownership - Nutrialys Medical Nutrition
Dominique Bligny
No relevant relationships to disclose
Christine Abraham
No relevant relationships to disclose
Jacques Philippe Moulinoux
Employment or Leadership Position - Nutrialys Medical Nutrition (U)
Consultant or Advisory Role - Nutrilays
Stock Ownership - Nutrialys Medical Nutrition